Tendon Extracellular Matrix Remodeling and Defective Cell Polarization in the Presence of Collagen VI Mutations.
Antigens
/ genetics
Biopsy
Cell Polarity
/ genetics
Collagen Type VI
/ genetics
Contracture
/ diagnostic imaging
Extracellular Matrix
/ genetics
Female
Fibroblasts
/ metabolism
Humans
Male
Matrix Metalloproteinase 2
/ genetics
Muscle, Skeletal
/ pathology
Muscular Dystrophies
/ congenital
Mutation
/ genetics
Proteoglycans
/ genetics
Sclerosis
/ diagnostic imaging
Tendons
/ diagnostic imaging
Bethlem myopathy
NG2 proteoglycan
Ullrich congenital muscular dystrophy
cell polarization
cell-extracellular matrix interactions
collagen VI
extracellular matrix remodeling
metalloproteinase 2
pericellular matrix
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
11 02 2020
11 02 2020
Historique:
received:
20
12
2019
revised:
05
02
2020
accepted:
07
02
2020
entrez:
15
2
2020
pubmed:
15
2
2020
medline:
27
2
2021
Statut:
epublish
Résumé
Mutations in collagen VI genes cause two major clinical myopathies, Bethlem myopathy (BM) and Ullrich congenital muscular dystrophy (UCMD), and the rarer myosclerosis myopathy. In addition to congenital muscle weakness, patients affected by collagen VI-related myopathies show axial and proximal joint contractures, and distal joint hypermobility, which suggest the involvement of tendon function. To gain further insight into the role of collagen VI in human tendon structure and function, we performed ultrastructural, biochemical, and RT-PCR analysis on tendon biopsies and on cell cultures derived from two patients affected with BM and UCMD. In vitro studies revealed striking alterations in the collagen VI network, associated with disruption of the collagen VI-NG2 (Collagen VI-neural/glial antigen 2) axis and defects in cell polarization and migration. The organization of extracellular matrix (ECM) components, as regards collagens I and XII, was also affected, along with an increase in the active form of metalloproteinase 2 (MMP2). In agreement with the in vitro alterations, tendon biopsies from collagen VI-related myopathy patients displayed striking changes in collagen fibril morphology and cell death. These data point to a critical role of collagen VI in tendon matrix organization and cell behavior. The remodeling of the tendon matrix may contribute to the muscle dysfunction observed in BM and UCMD patients.
Identifiants
pubmed: 32053901
pii: cells9020409
doi: 10.3390/cells9020409
pmc: PMC7072441
pii:
doi:
Substances chimiques
Antigens
0
COL6A2 protein, human
0
Col6a1 protein, human
0
Collagen Type VI
0
Proteoglycans
0
chondroitin sulfate proteoglycan 4
0
MMP2 protein, human
EC 3.4.24.24
Matrix Metalloproteinase 2
EC 3.4.24.24
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Mol Vis. 2014 May 13;20:638-48
pubmed: 24868138
J Orthop Res. 2015 Jun;33(6):793-9
pubmed: 25640030
J Musculoskelet Neuronal Interact. 2011 Jun;11(2):115-23
pubmed: 21625048
Matrix Biol. 2016 Sep;55:90-105
pubmed: 26944560
J Biol Chem. 2002 Dec 20;277(51):49120-6
pubmed: 12354766
Exerc Sport Sci Rev. 2007 Jul;35(3):126-34
pubmed: 17620931
Curr Protoc Cell Biol. 2011 Sep;Chapter 4:Unit4.19
pubmed: 21898338
Eur J Dermatol. 2004 Jul-Aug;14(4):221-9
pubmed: 15319154
J Med Genet. 2005 Sep;42(9):673-85
pubmed: 16141002
J Biol Chem. 2014 Apr 11;289(15):10293-307
pubmed: 24563484
J Invest Dermatol. 2011 Jan;131(1):99-107
pubmed: 20882040
Matrix Biol. 2011 Jan;30(1):53-61
pubmed: 20951202
Am J Med Genet A. 2005 Jan 30;132A(3):296-301
pubmed: 15690374
J Cell Biol. 1986 Mar;102(3):703-10
pubmed: 3456350
J Biol Chem. 2013 May 17;288(20):14320-31
pubmed: 23564457
J Biol Chem. 2008 Jul 18;283(29):20170-80
pubmed: 18400749
Connect Tissue Res. 2014 Oct-Dec;55(5-6):397-402
pubmed: 25166893
Front Aging Neurosci. 2016 Jun 08;8:131
pubmed: 27375477
Cell Tissue Res. 2009 Apr;336(1):79-89
pubmed: 19221802
J Biol Chem. 2002 Jan 18;277(3):1949-56
pubmed: 11707460
Eur J Biochem. 1984 Aug 1;142(3):493-502
pubmed: 6432530
J Equine Sci. 2013;24(2):17-24
pubmed: 24833997
Matrix Biol. 2018 Oct;71-72:348-367
pubmed: 29277723
Connect Tissue Res. 2012;53(1):2-13
pubmed: 21851252
Methods Mol Biol. 2004;285:171-7
pubmed: 15269412
Matrix Biol. 2009 Oct;28(8):480-9
pubmed: 19698785
Scientifica (Cairo). 2013;2013:130451
pubmed: 24455428
Matrix Biol. 2012 Apr;31(3):187-96
pubmed: 22226732
Biochem J. 1996 May 15;316 ( Pt 1):1-11
pubmed: 8645190
Structure. 2003 Sep;11(9):1179-88
pubmed: 12962636
Muscles Ligaments Tendons J. 2014 Feb 24;3(4):281-6
pubmed: 24596691
Matrix Biol. 2001 Nov;20(7):475-86
pubmed: 11691587
J Cell Sci. 1992 Nov;103 ( Pt 3):857-62
pubmed: 1478975
J Biol Chem. 2008 Apr 18;283(16):10658-70
pubmed: 18276594
Am J Pathol. 2015 May;185(5):1436-47
pubmed: 25797646
PLoS One. 2011;6(9):e24753
pubmed: 21935455
J Struct Biol. 2006 Jun;154(3):312-26
pubmed: 16713302
Biochim Biophys Acta. 2014 Sep;1842(9):1604-12
pubmed: 24907562
Autophagy. 2016 Dec;12(12):2484-2495
pubmed: 27656840
J Orthop Res. 2008 Mar;26(3):374-83
pubmed: 17868111
Eur J Paediatr Neurol. 2015 Sep;19(5):533-6
pubmed: 25978941
J Cell Biol. 1986 Aug;103(2):393-404
pubmed: 3525575